Literature DB >> 20399697

Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping.

Timothy C Rodwell1, Anokhi J Kapasi, Marisa Moore, Feliciano Milian-Suazo, Beth Harris, L P Guerrero, Kathleen Moser, Steffanie A Strathdee, Richard S Garfein.   

Abstract

OBJECTIVES: To compare genotypes of Mycobacterium bovis strains from humans in Southern California with genotypes of M. bovis strains in cattle in Mexico and the USA to explore the possible origins of human infections.
METHODS: We conducted a descriptive analysis of M. bovis genotypes from a binational population of humans and cattle using spacer oligonucleotide typing (spoligotyping).
RESULTS: One hundred six human M. bovis spoligotypes were compared to spoligotypes from 496 Mexican cattle and 219 US cattle. Twelve spoligotype patterns were identified among human cases and 126 spoligotype patterns were detected in cattle. Over 91% (97/106) of the human M. bovis isolates had spoligotypes that were identical to those found in Mexican cattle. Four human cases had spoligotypes that matched both cattle born in Mexico and in the USA. Nine human cases had spoligotypes that did not match cattle born in Mexico or the USA.
CONCLUSIONS: Our data indicate that the population of M. bovis strains causing human TB disease in Southern California is closely related to the M. bovis strain population found in Mexican cattle and supports existing epidemiological evidence that human M. bovis disease in San Diego likely originated from Mexican cattle.
Copyright © 2010 International Society for Infectious Diseases. All rights reserved.

Entities:  

Keywords:  Molecular epidemiology; Mycobacterium bovis; Spoligotyping; Tuberculosis

Mesh:

Substances:

Year:  2010        PMID: 20399697      PMCID: PMC2920372          DOI: 10.1016/j.ijid.2009.11.037

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  41 in total

1.  Study of restriction fragment length polymorphism analysis and spoligotyping for epidemiological investigation of Mycobacterium bovis infection.

Authors:  E Costello; D O'Grady; O Flynn; R O'Brien; M Rogers; F Quigley; J Egan; J Griffin
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis.

Authors:  S Samper; C Martín; A Pinedo; A Rivero; J Blázquez; F Baquero; D van Soolingen; J van Embden
Journal:  AIDS       Date:  1997-08       Impact factor: 4.177

3.  Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria.

Authors:  Simeon Cadmus; Si Palmer; Melissa Okker; James Dale; Karen Gover; Noel Smith; Keith Jahans; R Glyn Hewinson; Stephen V Gordon
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 4.  Abattoir surveillance: the U.S. experience.

Authors:  John B Kaneene; Roseann Miller; Robert M Meyer
Journal:  Vet Microbiol       Date:  2005-12-02       Impact factor: 3.293

5.  Spoligotype analysis of Mycobacterium bovis isolates from Northern México.

Authors:  Laura Cobos-Marín; Jesus Montes-Vargas; Martín Zumarraga; Angel Cataldi; Maria Isabel Romano; Iris Estrada-Garcia; Jorge A Gonzalez-y-Merchand
Journal:  Can J Microbiol       Date:  2005-11       Impact factor: 2.419

6.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Human tuberculosis caused by Mycobacterium bovis--New York City, 2001-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-06-24       Impact factor: 17.586

Review 8.  The importance of Mycobacterium bovis as a zoonosis.

Authors:  Charles Thoen; Philip Lobue; Isabel de Kantor
Journal:  Vet Microbiol       Date:  2006-01-18       Impact factor: 3.293

9.  An update on bovine tuberculosis programmes in Latin American and Caribbean countries.

Authors:  Isabel N de Kantor; Viviana Ritacco
Journal:  Vet Microbiol       Date:  2005-11-28       Impact factor: 3.293

10.  Usefulness of spoligotyping in molecular epidemiology of Mycobacterium bovis-related infections in South America.

Authors:  M J Zumárraga; C Martin; S Samper; A Alito; O Latini; F Bigi; E Roxo; M E Cicuta; F Errico; M C Ramos; A Cataldi; D van Soolingen; M I Romano
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

View more
  15 in total

1.  Single nucleotide polymorphisms in the Mycobacterium bovis genome resolve phylogenetic relationships.

Authors:  Deepti Joshi; N Beth Harris; Ray Waters; Tyler Thacker; Barun Mathema; Barry Krieswirth; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

2.  Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.

Authors:  Nathan W Furukawa; Mahri Z Haider; Sheanne J Allen; Sherry L Carlson; Scott W Lindquist
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

3.  Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil.

Authors:  Marcio Roberto Silva; Adalgiza da Silva Rocha; Ronaldo Rodrigues da Costa; Andrea Padilha de Alencar; Vania Maria de Oliveira; Antônio Augusto Fonseca Júnior; Mariana Lázaro Sales; Marina de Azevedo Issa; Paulo Martins Soares Filho; Omara Tereza Vianello Pereira; Eduardo Calazans dos Santos; Rejane Silva Mendes; Angela Maria de Jesus Ferreira; Pedro Moacyr Pinto Coelho Mota; Philip Noel Suffys; Mark Drew Crosland Guimarães
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

4.  Factors associated with genotype clustering of Mycobacterium tuberculosis isolates in an ethnically diverse region of southern California, United States.

Authors:  Timothy C Rodwell; Anokhi J Kapasi; Richard F W Barnes; Kathleen S Moser
Journal:  Infect Genet Evol       Date:  2012-09-13       Impact factor: 3.342

Review 5.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

6.  Isolation and molecular characterization of Mycobacterium bovis from Kafue lechwe (Kobus leche kafuensis) from Zambia.

Authors:  Sydney Malama; Tone Bjordal Johansen; John Bwalya Muma; Sydney Mwanza; Berit Djønne; Jacques Godfroid
Journal:  Trop Anim Health Prod       Date:  2013-10-22       Impact factor: 1.559

7.  Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance.

Authors:  Miriam Bobadilla-del Valle; Pedro Torres-González; Miguel Enrique Cervera-Hernández; Areli Martínez-Gamboa; Brenda Crabtree-Ramirez; Bárbara Chávez-Mazari; Narciso Ortiz-Conchi; Luis Rodríguez-Cruz; Axel Cervantes-Sánchez; Tomasa Gudiño-Enríquez; Carmen Cinta-Severo; José Sifuentes-Osornio; Alfredo Ponce de León
Journal:  PLoS Negl Trop Dis       Date:  2015-09-30

8.  Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.

Authors:  Mark Gallivan; Neha Shah; Jennifer Flood
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

9.  Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.

Authors:  Miriam Serrano; Natalia Elguezabal; Iker A Sevilla; María V Geijo; Elena Molina; Rakel Arrazuria; Alfonso Urkitza; Gareth J Jones; Martin Vordermeier; Joseba M Garrido; Ramón A Juste
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

10.  Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.

Authors:  Jennifer A Davidson; Miranda G Loutet; Catherine O'Connor; Cathriona Kearns; Robert M M Smith; Maeve K Lalor; H Lucy Thomas; Ibrahim Abubakar; Dominik Zenner
Journal:  Emerg Infect Dis       Date:  2017-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.